Close Asset Management LTD Adaptive Biotechnologies Corp Transaction History

Close Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$6.4 - $14.73 $9,504 - $21,874	-1,485 Reduced 99.0%	15 $0
Q3 2021 Nov 04, 2021	SELL	$30.02 - $39.87 $93,062 - $123,596	-3,100 Reduced 67.39%	1,500 $51,000
Q2 2021 Jul 27, 2021	BUY	$32.22 - $44.59 $148,212 - $205,114	4,600 New	4,600 $188,000

212

142M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.11B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Close Asset Management LTD with notifications on news.